Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Precise clinical classification of metabolic associated fatty liver disease].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology - 20 Apr 2026

Su W R, Ding J J, Pan Q, Chai J

Abstract excerpt

Metabolic associated fatty liver disease (MAFLD) is the most common chronic liver disease worldwide, and its significant clinical and pathophysiological heterogeneity poses a serious challenge to traditional "one-size-fits-all" diagnostic and therapeutic approaches. Therefore, constructing a precise clinical classification system to identify patient subgroups with varying risks and treatment responses has become...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artificial Intelligence
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Mass Index

Share to Fatty Liver

Share to Non-alcoholic Fatty Liver Disease

Share to Phenotype

Share to Precision Medicine

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 42036225
DOI: 10.3760/cma.j.cn501113-20251205-00519
PMCID: PMC13153938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Precise clinical classification of metabolic associated fatty liver disease].PMID 42036225Read ↗

The New Paradigm of Non-Alcoholic Fatty Liver Disease: Phenotypic Diversity of Metabolically Associated Fatty Liver DiseaseSemantic proximity Read ↗

Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision makingSemantic proximity Read ↗

Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine.Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read ↗

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive AnalysisSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Unraveling MASLD Through the Use of Omics TechnologiesSemantic proximity Read ↗

Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtypingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.